Loss ofMEF2Cfunction by enhancer mutation leads to neuronal mitochondria dysfunction and motor deficits in mice
preprint
OA: closed
Full text
1,634 characters
· extracted from
oa-html
· click to expand
Abstract
Genetic changes and epigenetic modifications are associated with neuronal dysfunction in the pathogenesis of neurodegenerative disorders. However, the mechanism behind genetic mutations in the non-coding region of genes that affect epigenetic modifications remains unclear. Here, we identified an ALS-associated SNP located in the intronic region of MEF2C (rs304152), residing in a putative enhancer element, using convolutional neural network. The enhancer mutation of MEF2C reduces own gene expression and consequently impairs mitochondrial function in motor neurons. MEF2C localizes and binds to the mitochondria DNA, and directly modulates mitochondria-encoded gene expression. CRISPR/Cas-9-induced mutation of the MEF2C enhancer decreases expression of mitochondria-encoded genes. Moreover, MEF2C mutant cells show reduction of mitochondrial membrane potential, ATP level but elevation of oxidative stress. MEF2C deficiency in the upper and lower motor neurons of mice impairs mitochondria-encoded genes, and leads to mitochondrial metabolic disruption and progressive motor behavioral deficits. Together, MEF2C dysregulation by the enhancer mutation leads to mitochondrial dysfunction and oxidative stress, which are prevalent features in motor neuronal damage and ALS pathogenesis. This genetic and epigenetic crosstalk mechanism provides insights for advancing our understanding of motor neuron disease and developing effective treatments.
Full Text Availability
The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (52)
- A pitfall for machine learning methods aiming to predict across cell types via crossref
- doi:10.3390/cells9122687 via crossref
- doi:10.1007/s00401-013-1199-1 via crossref
- doi:10.1016/j.brainres.2014.02.015 via crossref
- doi:10.1093/hmg/ddu279 via crossref
- doi:10.1007/s00401-015-1401-8 via crossref
- doi:10.1016/j.trsl.2018.10.002 via crossref
- doi:10.1186/s12929-022-00890-3 via crossref
- doi:10.1111/bpa.13012 via crossref
- doi:10.1038/ng.3622 via crossref
- doi:10.1093/hmg/ddt587 via crossref
- doi:10.1016/j.neuron.2018.02.027 via crossref
- doi:10.1038/s41576-019-0127-1 via crossref
- doi:10.1093/nar/gkz868 via crossref
- doi:10.1038/s41598-020-69790-6 via crossref
- doi:10.1038/nature13595 via crossref
- doi:10.1038/ng.3950 via crossref
- doi:10.1038/ncomms14774 via crossref
- doi:10.1038/s41467-021-23187-9 via crossref
- doi:10.1038/ng.3969 via crossref
- doi:10.1093/hmg/ddad142 via crossref
- doi:10.1111/acel.12679 via crossref
- doi:10.1007/978-1-0716-0676-6_15 via crossref
- doi:10.1126/sciadv.abh3568 via crossref
- doi:10.1038/mt.2013.247 via crossref
- doi:10.1016/j.cell.2013.09.011 via crossref
- doi:10.1084/jem.20071460 via crossref
- doi:10.3389/fgene.2012.00195 via crossref
- doi:10.1016/s0169-328x(01)00187-5 via crossref
- doi:10.1128/mcb.19.1.21 via crossref
- doi:10.4049/jimmunol.161.9.4795 via crossref
- doi:10.1002/ana.20624 via crossref
- doi:10.1002/1873-3468.12989 via crossref
- doi:10.3390/life11050432 via crossref
- doi:10.1073/pnas.91.24.11752 via crossref
- doi:10.1111/bph.12476 via crossref
- doi:10.1038/mp.2016.254 via crossref
- doi:10.1038/s41593-023-01315-6 via crossref
- doi:10.1038/s41593-023-01499-x via crossref
- doi:10.1016/j.molmed.2021.07.012 via crossref
- doi:10.1016/j.bbr.2016.04.044 via crossref
- doi:10.5607/en.2018.27.2.103 via crossref
- doi:10.7150/thno.56070 via crossref
- doi:10.1038/s42003-021-02034-z via crossref
- doi:10.1016/j.celrep.2014.03.019 via crossref
- doi:10.1152/jn.00665.2003 via crossref
- doi:10.1016/0006-8993(75)90286-3 via crossref
- doi:10.1523/jneurosci.5066-03.2004 via crossref
- doi:10.1016/j.bbagen.2009.08.002 via crossref
- doi:10.1152/ajpcell.00222.2006 via crossref
- doi:10.1016/j.jmb.2019.02.004 via crossref
- doi:10.1038/s41467-023-37507-8 via crossref
Source provenance
- crossref
- last seen: 2026-05-31T01:00:40.813638+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-06-13T17:26:54.343160+00:00